![0427-en-battistew-1922499-640x360.jpg](https://assets1.cbsnewsstatic.com/hub/i/r/2023/04/27/2e965f90-532d-4f48-afcb-7fc6b977aaa3/thumbnail/640x360/07613df524c04cd23db37b5eb48008e3/0427-en-battistew-1922499-640x360.jpg?v=a23cb4bdf4fa7f3cb72e5118085577f9#)
Eli Lilly seeks FDA approval for weight loss drug
Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.